Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 09-2010 | 09-2009 | 09-2008 | 12-2007 | |
| Sales | 111 | 639 | 700 | 774 | 0 |
| Cost of Goods | 147 | 135 | 132 | 163 | N/A |
| Gross Profit | -36 | 503 | 569 | 610 | 20 |
| Operating Expenses | 5,403 | 7,144 | 7,392 | 6,248 | 3,987 |
| Operating Income | -5,291 | -6,505 | -6,692 | -5,474 | -3,987 |
| Interest Expense | 7,567 | 361 | 1,733 | -104 | 0 |
| Other Income | 4,531 | -1,308 | -90 | 0 | 0 |
| Pre-tax Income | -8,327 | -8,173 | -8,515 | -5,370 | -3,987 |
| Income Tax | 1 | 1 | -7 | -1 | N/A |
| Net Income Continuous | -8,328 | -8,174 | -8,508 | -5,369 | -3,279 |
| Net Income Discontinuous | -538 | N/A | N/A | N/A | 0 |
| Net Income | $-8,867 | $-8,174 | $-8,508 | $-5,369 | $-5,369 |
| EPS Basic Total Ops | -5,686.86 | -5,620.50 | -11,024.82 | -7,638.11 | N/A |
| EPS Basic Continuous Ops | -5,338.93 | -5,633.45 | -11,034.85 | -7,645.38 | N/A |
| EPS Basic Discontinuous Ops | -347.93 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -5,686.86 | -5,620.50 | -11,024.82 | -7,638.11 | N/A |
| EPS Diluted Continuous Ops | -5,338.93 | -5,633.45 | -11,034.85 | -7,645.38 | N/A |
| EPS Diluted Discontinuous Ops | -347.93 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,082 | $-6,160 | $-5,305 | $-5,468 | $-3,967 |